Examkin

Patient Management

2074 soru

Tüm türler2,074Çoktan seçmeli1,048Çoklu seçim393Eşleştirme221Sıralama412
Soru 661Soru →

A 21-year-old man with type 1 diabetes mellitus is managed in the intensive care unit for diabetic ketoacidosis. Over the past 14 hours, he has received aggressive intravenous fluid resuscitation and a continuous intravenous regular insulin infusion. His fingerstick blood glucose is now 160 mg/dL160 \text{ mg/dL}. He is awake, alert, and requesting food. Arrange the following steps in the most appropriate chronological sequence to safely transition this patient's treatment and de-escalate therapy.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence requires first confirming the resolution of ketoacidosis (closed anion gap), followed by the administration of subcutaneous basal insulin, overlapping the intravenous and subcutaneous insulin for 1 to 2 hours, and finally discontinuing the intravenous infusion.
The successful management and evaluation of a patient recovering from diabetic ketoacidosis (DKA) relies heavily on appropriate treatment de-escalation protocols. First, the physician must confirm DKA resolution (anion gap ≤12 mEq/L\le 12 \text{ mEq/L}, blood pH>7.3pH > 7.3, and bicarbonate ≥15 mEq/L\ge 15 \text{ mEq/L}). Once confirmed and the patient is able to eat, subcutaneous basal insulin is administered. Crucially, intravenous regular insulin has a half-life of roughly 5 to 9 minutes, whereas subcutaneous insulin has a delayed onset of 1 to 2 hours. Therefore, the intravenous infusion must be maintained for a 1- to 2-hour overlap period to prevent a critical window of absolute insulin deficiency. Only after this overlap can the intravenous infusion be safely discontinued.

Adım Adım Çözüm

1
Confirm clinical and biochemical resolution of diabetic ketoacidosis.
Verification of an anion gap ≤12 mEq/L\le 12 \text{ mEq/L} and the patient's ability to tolerate oral intake.
Intravenous therapy should not be de-escalated until the underlying acid-base derangement is fundamentally resolved.
2
Administer subcutaneous basal insulin.
A depot of long-acting insulin is placed in the subcutaneous tissue.
To provide necessary baseline glycemic control as the patient transitions away from continuous infusions.
3
Overlap intravenous and subcutaneous insulin.
The intravenous regular insulin infusion is maintained for 1 to 2 hours.
Subcutaneous insulin requires 1 to 2 hours to be absorbed and reach systemic circulation. Overlapping prevents a critical gap in insulin coverage.
4
Discontinue intravenous insulin.
The continuous intravenous regular insulin infusion is stopped.
The subcutaneous insulin has now reached steady systemic levels, allowing safe cessation of the infusion without risk of rebound ketoacidosis.

Anahtar Kavram

When transitioning a patient from intravenous to subcutaneous insulin following diabetic ketoacidosis, a 1- to 2-hour overlap is mandatory to prevent rebound ketoacidosis due to the short half-life of intravenous insulin.
Soru 662Soru →

A 4545-year-old woman is evaluated in the nephrology clinic for a follow-up appointment. Three years ago, she underwent a deceased-donor renal transplantation for end-stage renal disease secondary to IgA nephropathy. Her maintenance immunosuppressive regimen includes tacrolimus, mycophenolate mofetil, and prednisone. Five days ago, she was evaluated at an urgent care center for fever, cough, and a pulmonary infiltrate on chest radiography, and was prescribed a course of oral clarithromycin for community-acquired pneumonia. Today, she reports that her pulmonary symptoms have improved, but she complains of a new-onset headache and a mild, bilateral hand tremor. Her blood pressure is 158/94158/94 mmHg, which is significantly increased from her baseline of 120/80120/80 mmHg. Physical examination reveals a fine resting tremor in both hands but is otherwise unremarkable. Laboratory studies show a serum creatinine level of 2.32.3 mg/dL; one month ago, it was 1.11.1 mg/dL. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Measure the serum tacrolimus trough level

Cevap

The correct answer is to measure the serum tacrolimus trough level.
The most appropriate next step is measuring the serum tacrolimus trough level. Tacrolimus is a calcineurin inhibitor metabolized primarily by the cytochrome P450 3A4 (CYP3A4) enzyme system in the liver and intestines. Clarithromycin, a macrolide antibiotic often prescribed for community-acquired pneumonia, is a potent CYP3A4 inhibitor. Concurrent administration of clarithromycin significantly decreases the clearance of tacrolimus, leading to supratherapeutic, toxic levels. Acute calcineurin inhibitor toxicity classically presents with nephrotoxicity (manifesting as an acute rise in serum creatinine due to intense afferent arteriolar vasoconstriction), new or worsening hypertension, and neurotoxicity (commonly presenting as a fine hand tremor, headache, or in severe cases, seizures). Given that the patient's clinical presentation is highly consistent with tacrolimus toxicity, confirming the elevated trough level is the essential first step to guide subsequent dose reduction and management.

Adım Adım Çözüm

1
Evaluate the patient's new symptoms and laboratory findings in the context of recent medication changes.
The patient has developed acute kidney injury (AKI), new-onset hypertension, and a neurologic symptom (tremor) shortly after starting clarithromycin.
Recognizing the temporal relationship between a new medication and new clinical findings is the first step in diagnosing adverse drug events.
2
Identify the pharmacokinetic interactions of the patient's current medication regimen.
Clarithromycin is a potent inhibitor of the cytochrome P450 3A4 (CYP3A4) enzyme, which is responsible for the hepatic and intestinal metabolism of tacrolimus.
Understanding CYP450 interactions is critical to safely managing patients on narrow-therapeutic-index immunosuppressants.
3
Correlate the clinical presentation with the physiological effects of the identified drug interaction.
Inhibition of CYP3A4 leads to supratherapeutic, toxic levels of tacrolimus. Tacrolimus toxicity classically presents with AKI (via afferent arteriolar vasoconstriction), hypertension, and neurotoxicity (such as tremor and headache).
Confirming that the patient's toxidrome perfectly matches the suspected interaction secures the clinical suspicion and avoids misdiagnosis.
4
Determine the most appropriate next step in monitoring and management.
Obtaining a serum tacrolimus trough level is required to confirm the toxicity and guide subsequent dose reduction.
Establishing the presence of drug toxicity through a non-invasive serum level is the safest and most guideline-concordant approach before pursuing invasive testing.

Anahtar Kavram

Calcineurin inhibitor toxicity secondary to CYP3A4 inhibition requires immediate monitoring of drug trough levels to guide therapeutic adjustment.
Soru 663Soru →

A 52-year-old man is evaluated for discharge planning. He was admitted 14 days ago with rapidly progressive ascending weakness and diagnosed with Guillain-Barré syndrome. His hospital course was complicated by respiratory failure requiring mechanical ventilation for 7 days. He was treated with a 5-day course of intravenous immunoglobulin and was successfully extubated 4 days ago. Currently, his vital signs are within normal limits, and he has had no episodes of autonomic instability for the past 72 hours. A stage 2 sacral pressure injury is present and healing well with standard barrier creams. Neurologic examination shows 4/5 strength in the upper extremities and 2/5 strength in the lower extremities, along with bilateral lower extremity areflexia. The patient requires maximum assistance from two caregivers to transfer from a bed to a wheelchair and cannot stand independently. Prior to this illness, he was fully independent, worked full-time, and ran 3 miles daily. He lives with his wife in a two-story home. Over the past 48 hours, he has enthusiastically participated in 3.5 hours of combined physical and occupational therapy daily without excessive fatigue or hemodynamic compromise. Which of the following is the most appropriate disposition for this patient?

Cevabı ve açıklamayı göster

Cevap: Transfer to an inpatient rehabilitation facility

Cevap

Transfer to an inpatient rehabilitation facility
The correct answer is the inpatient rehabilitation facility. This care setting is intended for patients who are medically stable enough to leave the acute hospital, have a significant functional deficit but a high potential for recovery, require close supervision by a physician, and can tolerate at least 3 hours of intensive therapy per day. This patient perfectly fits these criteria, having already demonstrated the stamina for 3.5 hours of daily therapy, making an inpatient rehabilitation facility the most appropriate disposition to maximize his return to full independence.

Adım Adım Çözüm

1
Assess the patient's medical stability and ongoing acute care needs.
The patient is extubated, hemodynamically stable, and has completed targeted acute medical therapy (IVIG) for Guillain-Barré syndrome. Acute hospital care is no longer strictly required.
Determines if the patient is ready for discharge from the acute care setting.
2
Evaluate the patient's functional deficits and home environment safety.
The patient requires maximum assistance from two caregivers for bed-to-wheelchair transfers and lives in a two-story home. Discharging him home is unsafe.
Eliminates home discharge options, indicating a need for a post-acute institutional care setting.
3
Determine the appropriate level of post-acute institutional care based on therapy tolerance and medical complexity.
The patient does not need prolonged ventilator weaning or complex wound care (ruling out LTACH). He has demonstrated the ability to tolerate 3.5 hours of therapy per day and has a high baseline functional status, fulfilling the criteria for an inpatient rehabilitation facility rather than a skilled nursing facility.
Differentiates between LTACH, IRF, and SNF admission criteria to maximize the patient's functional recovery.

Anahtar Kavram

Safe transitions of care rely on matching a patient's functional capacity, medical stability, and ability to tolerate intensive physical therapy with the specific admission criteria of post-acute care settings.
Soru 664Soru →

A 68-year-old man presents to the clinic with a 2-day history of severe pain, swelling, and redness in his right great toe. He states the pain is so intense he cannot tolerate wearing a shoe or having a bedsheet touch his foot. He experienced a similar episode 3 years ago, during which a joint fluid aspiration confirmed the presence of monosodium urate crystals. His past medical history includes ischemic cardiomyopathy with a left ventricular ejection fraction of 30%, stage 4 chronic kidney disease, and a hospitalized episode of upper gastrointestinal bleeding secondary to a gastric ulcer two years ago. Current medications include carvedilol, furosemide, and pantoprazole. Vital signs are temperature 37.2°C (99.0°F), blood pressure 134/86 mmHg, and pulse 82/min. Physical examination of the right foot shows marked erythema, swelling, and extreme tenderness over the first metatarsophalangeal joint. Recent laboratory studies reveal a serum creatinine of 2.7 mg/dL and an estimated glomerular filtration rate (eGFR) of 24 mL/min/1.73 m 2^2. Which of the following is the most appropriate initial pharmacologic intervention for this patient's acute symptoms?

Cevabı ve açıklamayı göster

Cevap: Oral prednisone

Cevap

Oral prednisone is the most appropriate initial pharmacologic intervention.
The correct intervention is oral prednisone because it is the safest and most effective systemic treatment for an acute gout flare in this highly complex patient. Standard first-line agents for acute gout include NSAIDs, colchicine, and glucocorticoids. However, this patient's advanced chronic kidney disease (stage 4), ischemic cardiomyopathy, and history of severe peptic ulcer disease represent absolute contraindications to NSAID therapy. Furthermore, colchicine clearance is heavily dependent on renal function; using it in a patient with an eGFR of 24 mL/min/1.73 m 2^2 carries an unacceptably high risk of severe toxicity, including fatal neuromyopathy and bone marrow suppression. Glucocorticoids bypass these specific organ toxicities and provide excellent acute anti-inflammatory relief.

Adım Adım Çözüm

1
Identify the primary clinical problem.
The patient is presenting with acute monoarticular arthritis of the first metatarsophalangeal joint (podagra), highly consistent with an acute gout flare given his prior crystal-proven history.
Establishing the correct diagnosis guides the selection of acute anti-inflammatory therapies rather than antimicrobial treatments.
2
Review the standard first-line therapies for an acute gout flare.
Standard therapies include nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, and systemic or intra-articular glucocorticoids.
First-line agents must be evaluated against the patient's specific risk profile.
3
Evaluate the patient's comorbidities to identify absolute or relative contraindications.
The patient has stage 4 chronic kidney disease (CKD), heart failure, and a history of peptic ulcer disease. This rules out NSAIDs (nephrotoxicity, fluid retention, gastrointestinal bleeding) and severely restricts colchicine use (requires normal to mildly impaired renal clearance).
Preventing iatrogenic harm is critical in complex patients with multiple organ system impairments.
4
Select the safest effective pharmacologic intervention.
Glucocorticoids, such as oral prednisone, bypass the renal and severe gastrointestinal risks of NSAIDs and colchicine, making them the safest systemic option for this patient.
Oral prednisone provides rapid anti-inflammatory action without the specific toxicities contraindicated by the patient's existing comorbidities.

Anahtar Kavram

In patients presenting with an acute gout flare who have significant contraindications to NSAIDs and colchicine (e.g., severe chronic kidney disease, heart failure, peptic ulcer disease), systemic or intra-articular glucocorticoids are the preferred first-line pharmacologic intervention.
Tahmini Süre:1m 15s
Soru 665Soru →

During a routine health maintenance visit, a 42-year-old female patient inquires about cancer screening recommendations. She feels completely well and has no medical complaints. Her medical history is unremarkable, and she takes no medications. She has never smoked cigarettes and does not consume alcohol. There is no known family history of any malignancies. Her last cervical cancer screening, which included high-risk human papillomavirus (HPV) cotesting, was performed 1 year ago and was normal. She has never undergone breast imaging. Based on current US Preventive Services Task Force (USPSTF) guidelines, which of the following is the most appropriate recommendation for breast cancer screening in this patient?

Cevabı ve açıklamayı göster

Cevap: Biennial screening mammography

Cevap

Biennial screening mammography
The correct recommendation is biennial screening mammography. In 2024, the US Preventive Services Task Force (USPSTF) finalized updated guidelines (Grade B recommendation) stating that all average-risk women should undergo biennial screening mammography starting at age 40 and continuing through age 74. This patient is 42 years old and at average risk, making her an appropriate candidate to initiate screening now on a two-year interval.

Adım Adım Çözüm

1
Evaluate the patient's demographic profile and risk factors.
The patient is a 42-year-old female with no family history of cancer, indicating she is at average risk for breast cancer.
Risk stratification dictates the appropriate screening modality, start age, and interval.
2
Identify the current evidence-based guideline for this patient demographic.
The USPSTF recommends initiating breast cancer screening with mammography at age 40.
Guidelines were updated in 2024 to address rising breast cancer incidence in younger women and to improve survival outcomes.
3
Determine the correct screening interval and modality.
The recommended interval is biennial (every 2 years) using screening mammography.
Biennial screening provides a favorable balance of benefits (mortality reduction) and harms (false positives, unnecessary biopsies) for average-risk women.

Anahtar Kavram

The USPSTF recommends biennial screening mammography for women aged 40 to 74 years who are at average risk for breast cancer.
Tahmini Süre:45s
Soru 666Soru →

A 58-year-old woman is evaluated in the clinic for a routine health maintenance examination. She feels well and reports no new symptoms. Her medical history includes essential hypertension and hyperlipidemia, both of which are well-controlled with lisinopril and atorvastatin. The patient reports a 25 pack-year smoking history but successfully quit smoking 10 years ago. Family history is significant for a mother who was diagnosed with colon cancer at age 66. The patient's most recent screenings include a normal colonoscopy 8 years ago, a negative screening mammogram 8 months ago, and a negative cervical cytology with high-risk human papillomavirus (hrHPV) co-testing 3 years ago. Vital signs and physical examination are unremarkable. Which of the following is the most appropriate next step in preventive care for this patient?

Cevabı ve açıklamayı göster

Cevap: Low-dose computed tomography of the chest

Cevap

Low-dose computed tomography of the chest
The correct answer is low-dose computed tomography (LDCT) of the chest. According to the United States Preventive Services Task Force (USPSTF) guidelines, annual screening for lung cancer with LDCT is indicated for adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. This 58-year-old patient has a 25 pack-year history and quit 10 years ago, placing her squarely within the eligibility criteria for screening.

Adım Adım Çözüm

1
Evaluate the patient's age and smoking history against lung cancer screening guidelines.
The patient is 58 years old, has a 25 pack-year smoking history, and quit 10 years ago.
To determine if she meets the USPSTF criteria for annual low-dose computed tomography (LDCT) screening.
2
Assess the need for colon cancer screening based on family history and prior colonoscopy.
Her mother was diagnosed at age 66. This does not change her from the average-risk 10-year screening interval. Her last colonoscopy was 8 years ago.
To rule out the need for a shortened colonoscopy interval, confirming the next test is due in 2 years.
3
Check current status for other age- and gender-appropriate screenings.
Mammogram is up to date (done 8 months ago, due biennially), Pap/HPV is up to date (done 3 years ago, due every 5 years), and she is too young for routine DEXA screening (starts at 65).
To eliminate the remaining preventive care options as inappropriate at this exact visit.

Anahtar Kavram

The USPSTF recommends annual lung cancer screening with LDCT for adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years.
Soru 667Soru →

A 48-year-old woman comes to the emergency department reporting a fever that began earlier today. She has a history of stage II breast cancer and received her second cycle of doxorubicin and cyclophosphamide chemotherapy 10 days ago. She notes mild fatigue but denies chills, cough, shortness of breath, abdominal pain, or dysuria. She lives with her husband a 15-minute drive from the hospital and has reliable transportation. Temperature is 38.5°C (101.3°F), blood pressure is 122/78 mm Hg, pulse is 88/min, and respirations are 16/min. Physical examination reveals a well-appearing woman. Her indwelling central venous port site is clean with no erythema or tenderness. The lungs are clear to auscultation.

Laboratory studies show:
Hemoglobin: 11.2 g/dL
Leukocyte count: 800/mm³
Absolute neutrophil count: 350/mm³
Platelet count: 140,000/mm³
Serum creatinine: 0.7 mg/dL

Chest radiography shows no infiltrates. Blood and urine cultures are obtained.

Which of the following is the most appropriate disposition and initial management plan for this patient?

Cevabı ve açıklamayı göster

Cevap: Discharge home with oral ciprofloxacin and amoxicillin-clavulanate

Cevap

Discharge home with oral ciprofloxacin and amoxicillin-clavulanate
The correct disposition is discharging the patient home with oral ciprofloxacin and amoxicillin-clavulanate. This patient presents with chemotherapy-induced febrile neutropenia (fever >38.3°C and absolute neutrophil count <500/mm³). The immediate priority is administering empiric broad-spectrum antibiotics. However, disposition depends on risk stratification. Using objective tools like the Multinational Association for Supportive Care in Cancer (MASCC) risk index, this patient is classified as low risk because she is hemodynamically stable, has a solid tumor (breast cancer), lacks severe symptoms or comorbid conditions (e.g., COPD, hypotension), and has an outpatient onset of fever. Current clinical guidelines state that low-risk patients with intact gastrointestinal absorption and excellent social support (reliable transportation, supportive partner, proximity to the hospital) can be safely discharged from the emergency department. They should be prescribed a combination of oral antibiotics that cover pseudomonas and other gram-negative/positive organisms, most commonly a fluoroquinolone (ciprofloxacin or levofloxacin) plus amoxicillin-clavulanate.

Adım Adım Çözüm

1
Identify the primary clinical emergency.
The patient has a fever (38.5°C) and an absolute neutrophil count (ANC) of 350/mm³, confirming the diagnosis of febrile neutropenia.
Recognizing febrile neutropenia is critical because it is an oncologic emergency requiring rapid empiric antibiotic therapy.
2
Risk-stratify the patient using objective clinical criteria.
The patient is hemodynamically stable, has no serious medical comorbidities (e.g., COPD, hypotension, dehydration), and is relatively asymptomatic aside from mild fatigue. Her Multinational Association for Supportive Care in Cancer (MASCC) risk index score is high (≥21), classifying her as low risk.
Risk stratification dictates the appropriate care setting and route of antibiotic administration.
3
Assess functional capacity and social support for care transitions.
The patient lives close to the hospital, has reliable transportation, and has a supportive husband at home.
Safe outpatient management of febrile neutropenia requires robust home support and the ability to return to the hospital rapidly if clinical deterioration occurs.
4
Determine the appropriate disposition based on risk level and social factors.
Discharge home from the emergency department with broad-spectrum oral antibiotics (e.g., a fluoroquinolone plus amoxicillin-clavulanate) is indicated.
Clinical guidelines support outpatient management for low-risk febrile neutropenia to minimize hospital-acquired infections and improve patient quality of life without compromising outcomes.

Anahtar Kavram

Patients with low-risk febrile neutropenia (determined by objective scoring systems like MASCC) who have reliable social support and rapid access to medical care can be safely discharged home from the emergency department on empiric oral broad-spectrum antibiotics.
Soru 668Soru →

A 68-year-old man with New York Heart Association (NYHA) class III heart failure with reduced ejection fraction and chronic kidney disease (baseline estimated glomerular filtration rate of 35 mL/min/1.73 m235 \text{ mL/min/1.73 m}^2) is discharged following a 5-day hospitalization for an acute heart failure exacerbation. His volume status has been optimized, and his symptoms are currently stable. His discharge medication regimen includes maximally tolerated doses of metoprolol succinate, newly initiated sacubitril-valsartan, empagliflozin, spironolactone, and a reduced maintenance dose of bumetanide. Which of the following laboratory parameters are strictly indicated for routine serial monitoring during his early outpatient transition phase over the next 1 to 2 weeks? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Serum potassium concentration; Serum creatinine concentration

Cevap

The parameters that must be strictly monitored are the serum potassium concentration and the serum creatinine concentration.
Guideline-directed medical therapy for heart failure with reduced ejection fraction utilizes combinations of medications (such as ARNIs, MRAs, and SGLT2 inhibitors) that profoundly influence renal hemodynamics and electrolyte clearance. In a patient with baseline chronic kidney disease, the concurrent blockade of the renin-angiotensin-aldosterone system with sacubitril-valsartan and spironolactone poses a severe risk for life-threatening hyperkalemia. Simultaneously, the tubuloglomerular feedback mechanisms activated by empagliflozin, combined with the efferent vasodilation from the ARB component and volume reduction from loop diuretics, predictably decrease the glomerular filtration rate. Current treatment guidelines universally recommend measuring serum electrolytes (specifically potassium) and renal function (creatinine/blood urea nitrogen) within 1 to 2 weeks of discharge or medication titration to distinguish benign, expected initial fluctuations from dangerous acute kidney injury or hyperkalemia.

Adım Adım Çözüm

1
Analyze the patient's new pharmacotherapeutic regimen and baseline comorbidities.
The patient has Stage 3b chronic kidney disease and is taking a multidrug regimen including sacubitril-valsartan, spironolactone, empagliflozin, and bumetanide.
Identifying overlapping toxicities and mechanisms of action is essential to anticipate adverse events during care transitions.
2
Evaluate the risk profile of the regimen on renal hemodynamics and electrolytes.
The combination of an ARNI (sacubitril-valsartan) and a mineralocorticoid receptor antagonist (spironolactone) severely impairs potassium excretion, while the addition of an SGLT2 inhibitor (empagliflozin) and a loop diuretic (bumetanide) reduces intravascular volume and alters intraglomerular pressure.
Patients with preexisting chronic kidney disease are highly susceptible to sudden hemodynamic shifts, predisposing them to hyperkalemia and acute kidney injury.
3
Assess the clinical utility of the other proposed laboratory tests in this specific timeframe and pharmacological context.
BNP is artificially elevated by sacubitril and cannot be used; glucosuria is a mandatory physiologic consequence of empagliflozin; and HbA1c requires months to reflect clinical changes.
Test selection must be timely, accurate in the presence of interfering drugs, and capable of generating actionable clinical decisions.

Anahtar Kavram

Early outpatient monitoring for patients initiated on comprehensive guideline-directed medical therapy for heart failure (particularly ARNIs, MRAs, and SGLT2 inhibitors) must prioritize serum potassium and creatinine due to the high risk of hyperkalemia and hemodynamic acute kidney injury, while recognizing that ARNIs invalidate standard BNP measurements.
Soru 669Soru →

A 64-year-old man with end-stage renal disease on hemodialysis presents to the emergency department with profound generalized weakness and shortness of breath. He missed his last two scheduled dialysis sessions due to inclement weather. His pulse is 42/min, blood pressure is 98/60 mm Hg, and respiratory rate is 22/min. Physical examination reveals generalized flaccid muscle weakness and diminished deep tendon reflexes. A stat 12-lead electrocardiogram demonstrates a wide QRS complex, prolonged PR interval, absent P waves, and a pattern resembling a sine wave. Which of the following are the most appropriate simultaneous initial stabilization steps?

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Intravenous administration of calcium gluconate; Intravenous administration of regular insulin and dextrose

Cevap

The most appropriate simultaneous initial stabilization steps are the intravenous administration of calcium gluconate and the intravenous administration of regular insulin with dextrose.
The patient's presentation of missed dialysis sessions, profound muscle weakness, and a 12-lead electrocardiogram demonstrating a sine-wave pattern is highly specific for severe, life-threatening hyperkalemia. This is a medical emergency with a high risk of imminent progression to ventricular fibrillation or asystole. Initial stabilization requires two concurrent physiological strategies: antagonism of potassium's effect on the cardiac resting membrane potential, and rapid intracellular shifting of potassium. Intravenous calcium (gluconate or chloride) directly stabilizes the cardiac myocyte membrane within minutes. Simultaneously, intravenous regular insulin rapidly shifts potassium into cells by stimulating the Na+/K+-ATPase pump. Dextrose is always administered with the insulin to prevent profound hypoglycemia.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and diagnostic findings.
The patient has end-stage renal disease, missed dialysis, bradycardia, and a classic sine-wave pattern on the electrocardiogram.
Identifying the sine-wave pattern is critical as it indicates severe hyperkalemia with an imminent risk of cardiac arrest.
2
Determine the priority of interventions for unstable hyperkalemia.
Immediate stabilization requires cardiac membrane protection followed by rapid intracellular shifting of potassium.
Patients with significant electrocardiographic changes from hyperkalemia must receive temporizing medical therapy before definitive excretory treatments can be arranged.
3
Select the appropriate pharmacologic agents.
Intravenous calcium gluconate provides immediate membrane stabilization, while intravenous insulin and dextrose rapidly shift potassium intracellularly.
These agents work rapidly (within minutes) to avert fatal arrhythmias while definitive removal methods (like hemodialysis) are prepared.

Anahtar Kavram

The initial stabilization of severe hyperkalemia with electrocardiographic changes requires immediate intravenous calcium for cardiac membrane stabilization and intravenous insulin with dextrose for rapid intracellular potassium shifting.
Soru 670Soru →

A 52-year-old man is hospitalized for an acute manic episode characterized by severe psychomotor agitation, grandiose delusions, and a decreased need for sleep. He has a history of bipolar I disorder but has been nonadherent to medications for the past two years. After initial stabilization with an atypical antipsychotic, the decision is made to initiate lithium therapy for long-term mood stabilization. The patient has no other significant past medical history and takes no other medications. His vital signs and physical examination are within normal limits. Which of the following baseline investigations are indicated prior to starting this specific pharmacotherapy? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Thyroid-stimulating hormone; Serum calcium and renal function panel; Electrocardiogram

Cevap

The indicated baseline tests are thyroid-stimulating hormone, a serum calcium and renal function panel, and an electrocardiogram.
Lithium is a primary mood stabilizer with a narrow therapeutic index and specific organ toxicities. Baseline monitoring must evaluate for underlying conditions that lithium could exacerbate or that could affect its renal clearance. A renal function panel is mandatory because lithium is entirely renally excreted and can cause nephrogenic diabetes insipidus or chronic tubulointerstitial nephropathy. Baseline serum calcium is required because lithium can alter calcium homeostasis by causing hyperparathyroidism. Thyroid-stimulating hormone testing is necessary because lithium frequently causes hypothyroidism or goiter. Finally, an electrocardiogram is indicated for patients over the age of 40 (or those with pre-existing cardiac disease) because lithium can cause sinus node dysfunction, atrioventricular block, and repolarization changes.

Adım Adım Çözüm

1
Identify the proposed treatment and its pharmacologic profile.
The patient is starting lithium for bipolar I disorder.
Different mood stabilizers have entirely distinct toxicity profiles and organ clearance mechanisms.
2
Recall the organ systems affected by lithium toxicity.
Lithium primarily affects the kidneys (nephropathy, diabetes insipidus), thyroid (hypothyroidism), parathyroid (hypercalcemia), and cardiac conduction system.
Identifying the target organs dictates which baseline laboratory and diagnostic tests are mandatory to establish a physiological baseline.
3
Select the appropriate tests based on the patient's specific demographics.
The patient requires evaluation of thyroid function, renal function, and serum calcium. Because he is over 40 years of age, an electrocardiogram is also indicated.
Age is a critical determining factor for baseline cardiac evaluation when starting this medication, as the risk for subclinical cardiac disease is higher.

Anahtar Kavram

Baseline physiological monitoring for lithium initiation includes evaluation of renal function, serum calcium, and thyroid function, as well as an electrocardiogram in patients over 40 years of age.
Tahmini Süre:1m 30s
Soru 671Soru →

A primary care physician is reviewing the charts of four patients scheduled for clinic visits today. Identify the single most appropriate preventive screening test indicated for each patient based on current guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 66-year-old healthy female with no previous bone mineral density evaluations
A 23-year-old asymptomatic female who is sexually active with a new male partner
A 66-year-old male with a past history of smoking 10 cigarettes daily for 15 years
A 45-year-old asymptomatic male with average risk and no prior gastrointestinal workup

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The 66-year-old female matches with DXA; the 23-year-old female matches with Chlamydia trachomatis testing; the 66-year-old male matches with Abdominal ultrasonography; and the 45-year-old male matches with Colonoscopy or fecal immunochemical test.
Each patient demographic exactly matches a specific Grade A or B recommendation by national preventive task forces. DXA is for women 65+; Chlamydia NAAT is for sexually active women under 25; abdominal ultrasound is for men 65-75 with a smoking history; and colon cancer screening begins at 45.

Adım Adım Çözüm

1
Evaluate the 66-year-old female's screening needs.
Identify osteoporosis screening.
Women aged 65 and older require routine bone mineral density screening via DXA.
2
Evaluate the 23-year-old female's screening needs.
Identify sexually transmitted infection screening.
Sexually active women under the age of 25 require routine chlamydia screening.
3
Evaluate the 66-year-old male's screening needs.
Identify abdominal aortic aneurysm (AAA) screening.
Men aged 65 to 75 with any smoking history require a one-time ultrasound for AAA.
4
Evaluate the 45-year-old male's screening needs.
Identify colorectal cancer screening.
Average-risk adults should begin colorectal cancer screening at age 45.

Anahtar Kavram

Age and Risk-Based Preventive Screening Guidelines
Soru 672Soru →

A 2424-year-old man with type 11 diabetes mellitus is admitted to the intensive care unit for diabetic ketoacidosis. He is initially managed with vigorous intravenous normal saline resuscitation and a continuous regular insulin infusion. Arrange the following sequential steps regarding the monitoring of his condition and the subsequent adjustment of his therapeutic regimen in the correct chronological order, from first to last.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: monitor glucose and the anion gap first, add dextrose to intravenous fluids when glucose falls below 200 mg/dL200\text{ mg/dL}, administer subcutaneous insulin once the anion gap closes, and finally discontinue the intravenous insulin infusion 11 to 22 hours later.
The management of diabetic ketoacidosis requires sequential monitoring and careful therapeutic adjustments. First, rigorous tracking of glucose and the anion gap establishes the patient's baseline trajectory. Second, because blood glucose normalizes more rapidly than ketones clear, dextrose must be added to the intravenous fluids so that the insulin drip can safely continue to halt ketogenesis without causing hypoglycemia. Third, once ketoacidosis is fully resolved (indicated by a closed anion gap) and the patient can tolerate an oral diet, a subcutaneous basal insulin dose is administered. Finally, the continuous intravenous insulin must be maintained for an additional 11 to 22 hours after the subcutaneous injection to prevent a critical gap in insulin coverage, which would otherwise trigger rebound ketoacidosis.

Adım Adım Çözüm

1
Establish the baseline monitoring frequency for metabolic parameters.
Blood glucose is tracked hourly and the basic metabolic panel is checked every 22 to 44 hours.
This intensive monitoring safely tracks the resolution of ketoacidosis and detects early signs of iatrogenic hypoglycemia or electrolyte shifts.
2
Adjust the composition of the intravenous fluids based on glucose trends.
Intravenous dextrose is added to the fluid regimen when the blood glucose reaches 200 mg/dL200\text{ mg/dL}.
The regular insulin infusion must be maintained to clear serum ketones even after glucose levels normalize; dextrose prevents the patient from becoming severely hypoglycemic.
3
Initiate subcutaneous maintenance therapy based on metabolic resolution.
Subcutaneous basal insulin is administered once the anion gap closes (leq12 mEq/L\\leq 12\text{ mEq/L}) and the patient can eat.
Resolution of the elevated anion gap indicates that the underlying state of ketogenesis has been corrected.
4
Safely stop the continuous intravenous therapy.
The intravenous insulin pump is turned off 11 to 22 hours after the subcutaneous injection.
This overlap period ensures continuous systemic insulin coverage while the subcutaneous depot is absorbed into the bloodstream.

Anahtar Kavram

Monitoring and stepwise transition of therapy in diabetic ketoacidosis
Soru 673Soru →

A 75-year-old man with advanced ischemic cardiomyopathy is evaluated for hospital discharge following his third admission for acute decompensated heart failure in the past two months. Despite maximal optimization of guideline-directed medical therapy, he experiences intractable dyspnea at rest.

During this admission, his hemodynamics and dyspnea were stabilized only after initiating a continuous intravenous infusion of dobutamine. Two separate attempts to wean the dobutamine infusion resulted in immediate recurrent pulmonary edema and severe respiratory distress.

The patient is not a candidate for advanced heart failure therapies, such as a left ventricular assist device or heart transplantation, due to multiple severe medical comorbidities. During a family meeting, the patient is fully oriented and states, "I know my time is short. I just want to go back to my own house and be comfortable. I do not want any more aggressive treatments to try to fix my heart." His wife and adult daughter live with him and are fully capable of providing 24-hour physical assistance.

Which of the following is the most appropriate care setting transition for this patient?

Cevabı ve açıklamayı göster

Cevap: Discharge home with routine hospice care

Cevap

Discharge home with routine hospice care
The correct disposition perfectly aligns the patient's medical needs, social support, and goals of care. The patient has end-stage heart failure with an estimated prognosis of less than six months and explicitly desires comfort care at home. A common misconception is that patients dependent on continuous intravenous inotropes cannot be discharged to a residential setting. However, when medications like dobutamine or milrinone are used for palliation (to relieve intractable dyspnea rather than as a bridge to transplant), routine home hospice agencies are fully equipped to manage these infusions. Because his symptoms are well-controlled on the current dose and he has capable family caregivers, he meets the criteria for routine home hospice care.

Adım Adım Çözüm

1
Determine the patient's goals of care based on his clinical status and expressed wishes.
The patient has end-stage heart failure, is not a candidate for advanced therapies, and explicitly prioritizes comfort at home over life-prolonging treatment.
Establishing the overarching goal (palliative vs. restorative) dictates the entire trajectory of care setting transitions.
2
Evaluate the feasibility of managing the patient's current medical interventions in the preferred setting.
The patient is dependent on a continuous IV dobutamine infusion for symptom control (relief of dyspnea).
Some intensive treatments limit discharge options; however, palliative inotropes are a recognized exception that can be administered at home.
3
Synthesize the patient's goals, medical needs, and social support to select the precise disposition.
The patient's desire for comfort at home, presence of 24-hour family support, and need for palliative dobutamine make home hospice the perfect fit. General inpatient hospice is not indicated as his symptoms are currently stable on the infusion.
Matching the patient's clinical stability and psychosocial support with the correct tier of hospice care prevents inappropriate facility admissions.

Anahtar Kavram

Palliative continuous intravenous inotropes (e.g., dobutamine, milrinone) can be safely managed in the home setting by hospice agencies to provide symptom relief for patients with end-stage heart failure who wish to transition to comfort-focused care.
Soru 674Soru →

A 38-year-old woman comes to the clinic for a routine follow-up visit. Four weeks ago, she was diagnosed with active pulmonary tuberculosis and began standard intensive phase treatment with isoniazid, rifampin, pyrazinamide, ethambutol, and pyridoxine. Today, she reports feeling well and notes that her initial cough, fevers, and night sweats have completely resolved. She denies experiencing any nausea, vomiting, abdominal pain, fatigue, dark urine, or yellowing of her eyes. Vital signs are within normal limits. Physical examination reveals clear lungs bilaterally and a soft, non-tender abdomen with no hepatomegaly.

Laboratory results are as follows:

Laboratory TestResultReference Range
Aspartate aminotransferase (AST)145 U/L8-40 U/L
Alanine aminotransferase (ALT)160 U/L7-45 U/L
Alkaline phosphatase85 U/L40-120 U/L
Total bilirubin0.8 mg/dL0.1-1.2 mg/dL

Which of the following is the most appropriate next step in the management of this patient's therapy?

Cevabı ve açıklamayı göster

Cevap: Continue the current medication regimen and repeat liver chemistries in 1 to 2 weeks

Cevap

Continue the current medication regimen and repeat liver chemistries in 1 to 2 weeks
The correct action is to continue the current medication regimen and repeat liver chemistries in 1 to 2 weeks. Isoniazid, rifampin, and pyrazinamide are hepatotoxic medications used during the intensive phase of tuberculosis treatment. It is very common for patients to develop mild to moderate asymptomatic elevations in serum transaminases (drug-induced transaminitis) due to hepatic adaptation, which does not require treatment cessation. Current guidelines mandate the immediate discontinuation of hepatotoxic antitubercular medications only if serum transaminases exceed 33 times the upper limit of normal (ULN) in the presence of hepatitis symptoms (e.g., nausea, vomiting, right upper quadrant pain, jaundice, fatigue), or if they exceed 55 times the ULN in a completely asymptomatic patient. This patient is feeling well and exhibits no symptoms, while her AST and ALT are elevated to roughly 3.53.5 to 44 times the ULN. Because she has not reached the 55 times ULN threshold for asymptomatic patients, the most appropriate management is to safely maintain her current, effective regimen while monitoring her liver chemistries closely (e.g., in 1 to 2 weeks) to ensure they do not continue to climb.

Adım Adım Çözüm

1
Evaluate the patient's clinical presentation and isolated laboratory abnormalities.
The patient is completely asymptomatic, but her AST and ALT levels are elevated to roughly 3.53.5 to 44 times the upper limit of normal (ULN), with normal alkaline phosphatase and total bilirubin.
Establishing the presence or absence of hepatitis symptoms is the critical branch point in monitoring drug-induced hepatotoxicity.
2
Apply standard treatment and monitoring guidelines for antitubercular therapy.
Guidelines state that hepatotoxic drugs should only be stopped if transaminases are >5>5 times the ULN in asymptomatic patients, or >3>3 times the ULN in symptomatic patients (e.g., those with jaundice, nausea, or abdominal pain).
Differentiating between expected, benign hepatic adaptation and severe, dangerous hepatotoxicity prevents unnecessary disruption of life-saving therapy.
3
Determine the optimal intervention based on the clinical parameters.
Since the patient's transaminases are <5<5 times the ULN and she lacks symptoms, her regimen should be continued without interruption, coupled with close serial monitoring.
Continuing the medications prevents the emergence of drug-resistant tuberculosis while keeping the patient under appropriate surveillance.

Anahtar Kavram

During tuberculosis therapy, mild asymptomatic elevations in transaminases represent hepatic adaptation; therapy should only be discontinued if transaminases exceed 55 times the upper limit of normal in asymptomatic patients or 33 times the limit in symptomatic patients.
Soru 675Soru →

A 56-year-old man is transferred to the emergency department after vomiting approximately 800 mL of bright red blood. He has a history of alcohol-associated cirrhosis and noncompliance with medical follow-up. Upon arrival, he is lethargic, responds only to painful stimuli, and continues to have passive regurgitation of dark blood. Temperature is 36.4°C (97.5°F), blood pressure is 78/48 mmHg, pulse is 132/min, and respiratory rate is 24/min. Oxygen saturation is 91% on room air. Physical examination reveals marked scleral icterus, spider angiomas, and a distended abdomen with a positive fluid wave. Bilateral large-bore intravenous catheters are placed. Rapid infusion of balanced crystalloids and group O-negative packed red blood cells is initiated, along with intravenous octreotide and ceftriaxone.

Which of the following procedural interventions are indicated as the immediate next steps in this patient's management? (Select two)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Endotracheal intubation; Upper gastrointestinal endoscopy

Cevap

The correct procedural interventions are endotracheal intubation to protect the airway and an urgent upper gastrointestinal endoscopy to achieve definitive hemostasis.
This patient presents with massive upper gastrointestinal bleeding secondary to suspected ruptured esophageal varices in the setting of decompensated cirrhosis. The immediate priorities in managing any unstable hemorrhagic patient follow the ABCs (Airway, Breathing, Circulation). Due to his lethargy and ongoing hematemesis, he lacks protective airway reflexes and is at exceptionally high risk for pulmonary aspiration. Therefore, endotracheal intubation is the critical first procedural step to secure the airway. Once the airway is protected and initial fluid and pharmacologic resuscitation (e.g., octreotide, ceftriaxone) are actively underway, the most appropriate definitive procedural intervention is an urgent upper gastrointestinal endoscopy to directly identify the bleeding source and perform therapeutic band ligation or sclerotherapy.

Adım Adım Çözüm

1
Assess the patient's airway, breathing, and circulation (ABCs) in the context of massive hemorrhage.
The patient is in hemorrhagic shock (hypotensive, tachycardic) and has altered mental status (lethargy) with ongoing regurgitation of blood.
Airway compromise is the most immediate threat to life, superseding definitive hemorrhage control.
2
Identify the need for advanced airway management.
Endotracheal intubation must be performed immediately.
A lethargic patient vomiting blood cannot protect their airway and will likely aspirate during an endoscopic procedure if not intubated first.
3
Determine the appropriate definitive procedure for the underlying pathology.
Urgent upper gastrointestinal endoscopy is required.
Endoscopy allows direct visualization of the bleeding source (likely esophageal varices) and immediate therapeutic intervention such as endoscopic band ligation.

Anahtar Kavram

Prioritization of airway protection and sequential endoscopic intervention in acute variceal hemorrhage
Soru 676Soru →

A 6262-year-old woman is evaluated in the preoperative clinic prior to an elective right hemicolectomy for colon cancer scheduled in one week. Her medical history is significant for a mechanical mitral valve replacement performed 55 years ago, paroxysmal atrial fibrillation, and essential hypertension. Her current medications include warfarin, metoprolol, and lisinopril. She reports excellent medication compliance and denies any recent dyspnea, orthopnea, chest pain, or palpitations. Her vital signs are within normal limits. Physical examination shows a well-healed median sternotomy scar and a crisp mechanical heart valve click without murmurs. Her lungs are clear to auscultation. Recent laboratory results show an International Normalized Ratio (INR) of 3.23.2. Which of the following perioperative management steps are indicated for this patient? (Select all that apply.)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Discontinuation of warfarin 55 days prior to surgery; Initiation of therapeutic-dose low-molecular-weight heparin bridging 33 days prior to surgery

Cevap

The correct interventions are the discontinuation of warfarin 5 days prior to surgery and the initiation of therapeutic-dose low-molecular-weight heparin (LMWH) bridging 3 days prior to surgery.
For elective procedures with high bleeding risk, warfarin must be withheld for approximately 5 days to allow the INR to normalize. Because this patient has a mechanical mitral valve, she is at high risk for valve thrombosis and systemic embolization. Therefore, she requires bridging therapy with a short-acting anticoagulant, such as therapeutic-dose low-molecular-weight heparin (LMWH), starting approximately 3 days prior to surgery (when the INR begins to fall below the therapeutic range). LMWH is then typically stopped 24 hours prior to the operation.

Adım Adım Çözüm

1
Assess the patient's bleeding risk associated with the scheduled surgery.
A right hemicolectomy is a major intra-abdominal procedure with a high bleeding risk.
High bleeding risk procedures require normalization of coagulation status prior to the operation to prevent catastrophic hemorrhage.
2
Evaluate the patient's thromboembolic risk to determine the need for bridging anticoagulation.
The patient has a mechanical mitral valve, which confers a high risk for arterial thromboembolism.
Patients with high thromboembolic risk (e.g., mechanical mitral valve, older mechanical aortic valves, recent stroke) require bridging therapy with a short-acting anticoagulant when warfarin is withheld.
3
Formulate a timeline for holding warfarin and initiating bridging therapy.
Warfarin should be stopped 5 days before surgery. LMWH bridging should start 3 days before surgery.
This timeline ensures that the INR falls to a safe level (less than 1.5) for surgery while minimizing the time the patient is unprotected against thromboembolism.

Anahtar Kavram

Patients at high risk for thromboembolism, such as those with a mechanical mitral valve, require bridging anticoagulation with therapeutic low-molecular-weight heparin or unfractionated heparin when warfarin is interrupted for procedures with a high bleeding risk.
Soru 677Soru →

A 35-year-old woman presents to the clinic reporting progressive weight gain, easy bruising, and proximal muscle weakness over the past eight months. She also notes new-onset facial hair growth and irregular menstrual cycles. Her blood pressure is 158/96 mmHg, and her body mass index is 34 kg/m². Physical examination is notable for facial plethora, a dorsocervical fat pad, and wide, violaceous striae over her lower abdomen. The physician suspects an endogenous hypercortisolism syndrome.

Arrange the following diagnostic steps in the most appropriate sequential order for evaluating this patient's condition, starting from the initial screening investigation to the most definitive preoperative localization test.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Measurement of 24-hour urinary free cortisol or late-night salivary cortisol, 2) Measurement of plasma ACTH concentration, 3) Magnetic resonance imaging (MRI) of the pituitary gland, and 4) Inferior petrosal sinus sampling (IPSS).
The diagnostic evaluation of Cushing syndrome strictly follows a stepwise algorithm to prevent misdiagnosis and unnecessary invasive procedures. First, hypercortisolism must be biochemically confirmed using 24-hour urinary free cortisol, late-night salivary cortisol, or a low-dose dexamethasone suppression test. Without this foundational step, further testing may yield false positives due to physiologic variations. Second, once hypercortisolism is established, a plasma ACTH level must be drawn to distinguish ACTH-dependent (elevated or normal ACTH) from ACTH-independent (suppressed ACTH) causes. Third, for ACTH-dependent cases, a pituitary MRI is performed since Cushing disease (pituitary adenoma) is the most common cause. Finally, if the MRI does not clearly identify an adenoma (e.g., the lesion is less than 6 mm) or if an ectopic source is suspected based on other clinical findings, inferior petrosal sinus sampling (IPSS) is performed to measure central-to-peripheral ACTH gradients and definitively localize the source before pursuing surgical resection.

Adım Adım Çözüm

1
Confirm the presence of pathological hypercortisolism.
Select 24-hour urinary free cortisol, late-night salivary cortisol, or a low-dose dexamethasone suppression test as the first step.
Biochemical evidence of excess cortisol must be definitively established to avoid false positives from physiological stress before proceeding to differentiate the cause.
2
Determine if the hypercortisolism is ACTH-dependent or ACTH-independent.
Select measurement of plasma ACTH concentration as the second step.
Once hypercortisolism is confirmed, ACTH levels differentiate primary adrenal disease (suppressed ACTH) from pituitary or ectopic sources (normal or elevated ACTH).
3
Perform anatomic localization of the suspected source.
Select pituitary MRI as the third step.
Because ACTH-dependent Cushing syndrome is most commonly caused by a pituitary adenoma (Cushing disease), an MRI of the pituitary is the first choice for localization.
4
Perform definitive functional localization if anatomic imaging is equivocal.
Select inferior petrosal sinus sampling (IPSS) as the final step.
If the MRI does not show a clear adenoma greater than 6 mm, IPSS is required to definitively distinguish between a pituitary and an ectopic source of ACTH prior to a surgical intervention.

Anahtar Kavram

The diagnostic workup for Cushing syndrome requires a strict sequential tiered approach: first confirming hypercortisolism, then determining ACTH dependence, followed by anatomic and functional localization of the source.
Tahmini Süre:2m 0s
Soru 678Soru →

A 56-year-old man with a history of alcohol-related cirrhosis presents to the hepatology clinic with newly developed, progressive abdominal distension. An in-office ultrasound confirms moderate ascites without hepatic vein thrombosis. The patient is hemodynamically stable, denies abdominal pain or fever, and has normal renal function. Arrange the following steps in the most appropriate chronological sequence for the evaluation, step-wise management, and long-term monitoring of this patient's new-onset ascites.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with a diagnostic paracentesis, followed by sodium restriction and dual-diuretic therapy, strict monitoring of daily weight loss (maximum 0.5 kg/day), evaluation of urinary sodium if diuresis fails, and finally large-volume paracentesis for refractory cases.
The management of new-onset ascites requires a rigid sequence to ensure safety and efficacy. Diagnostic paracentesis is mandatory first to establish the etiology and rule out infection. Only then should medical therapy (sodium restriction and dual-diuretics) begin. During therapy, monitoring daily weight is critical to prevent renal injury (max 0.5 kg/day loss). If treatment fails, evaluating urinary sodium distinguishes non-adherence from true refractory ascites. Finally, large-volume paracentesis is reserved for confirmed refractory cases.

Adım Adım Çözüm

1
Perform diagnostic paracentesis.
Ascitic fluid analysis yields a serum-ascites albumin gradient (SAAG) and cell count.
Required for all new-onset ascites to establish the etiology and rule out spontaneous bacterial peritonitis before starting treatments that could alter fluid composition.
2
Start sodium restriction and diuretic therapy.
Initiation of fluid mobilization.
This serves as the first-line pharmacologic and lifestyle management for uncomplicated portal hypertensive ascites.
3
Monitor daily weights.
Titration of diuretics to ensure safe fluid removal.
Prevents intravascular depletion; weight loss must be capped at 0.5 kg/day in patients without peripheral edema.
4
Check urinary sodium excretion.
Differentiation between refractory ascites and dietary noncompliance.
Essential evaluation step if the patient fails to respond to maximal diuretic doses before resorting to invasive measures.
5
Perform large-volume paracentesis (LVP).
Rapid symptomatic relief and fluid control.
Indicated only when medical management definitively fails and ascites becomes truly refractory.

Anahtar Kavram

Step-wise Evaluation and Monitoring of Cirrhotic Ascites
Tahmini Süre:2m 0s
Soru 679Soru →

A 2828-year-old male construction worker is brought to the emergency department after falling approximately 66 meters (2020 feet) from scaffolding. He landed directly on his head and upper back. Emergency medical services placed him in a rigid cervical collar and on a long backboard. Upon arrival, the patient is awake and alert, reporting severe posterior neck pain and an inability to move his arms or legs.

Vital signs are:
Temperature: 36.2∘C36.2^\circ\text{C} (97.2∘F97.2^\circ\text{F})
Blood pressure: 74/42 mmHg74/42\text{ mmHg}
Heart rate: 48/min48\text{/min}
Respiratory rate: 10/min10\text{/min} with shallow, abdominal breathing
Oxygen saturation: 87%87\% on room air

Physical examination reveals flaccid paralysis, absent deep tendon reflexes, and loss of pain and temperature sensation below the level of the clavicles. His extremities are remarkably warm and flushed.

Arrange the following management steps in the most appropriate sequential order of priority for this patient's initial stabilization and triage.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence prioritizes the Advanced Trauma Life Support (ATLS) algorithm: secure the airway first, followed by volume resuscitation for circulation, then vasopressors for refractory neurogenic shock, followed by a comprehensive neurologic assessment, and finally definitive diagnostic imaging.
In trauma and critical care, management must follow a strict algorithmic approach to prevent immediate death. This patient has a high cervical spinal cord injury presenting with both impending respiratory failure (loss of phrenic nerve function) and neurogenic shock (loss of sympathetic tone causing vasodilation and bradycardia). According to the primary survey, securing the airway and ensuring adequate ventilation is the first indispensable step. Once the airway is secured, the profound hypotension must be addressed through a sequential approach of initial fluid resuscitation followed by vasopressor support to restore mean arterial pressure and prevent secondary ischemic damage to the spinal cord. Only after the patient is hemodynamically stable should the physician focus on the secondary survey (detailed neurological examination) and definitively diagnosing the anatomic lesion (MRI).

Adım Adım Çözüm

1
Secure the airway via endotracheal intubation with manual in-line stabilization.
Prevention of respiratory arrest from diaphragmatic paralysis.
The patient's bradypnea and hypoxia indicate impending respiratory failure due to high cervical spinal cord injury. Airway (A) and Breathing (B) always take absolute precedence.
2
Establish large-bore intravenous access and administer an isotonic fluid bolus.
Initial correction of relative hypovolemia.
Moving to Circulation (C), the patient presents with neurogenic shock (hypotension, bradycardia, warm extremities). Initial management requires crystalloid fluid administration to optimize preload.
3
Initiate an intravenous infusion of a vasopressor to maintain spinal cord perfusion.
Restoration of vascular tone and mean arterial pressure (MAP).
Neurogenic shock causes a loss of sympathetic tone. Once initial volume is given, vasopressors are critical to maintain a MAP of 85−90 mmHg85-90\text{ mmHg} to prevent secondary ischemic injury to the spinal cord.
4
Perform a comprehensive neurological examination to define the injury level.
Documentation of baseline neurologic deficits.
With ABCs stabilized, the Disability (D) component and secondary survey can be completed to formalize the extent of the spinal cord injury.
5
Transport the patient to the radiology suite for magnetic resonance imaging (MRI).
Identification of the specific anatomical injury (e.g., cord compression, ligamentous tear).
Definitive imaging can only be safely performed once the patient is hemodynamically stable and the airway is secured.

Anahtar Kavram

Initial stabilization of neurogenic shock and high cervical spine injuries requires strict adherence to the ABCDE trauma algorithm, prioritizing airway protection and hemodynamic resuscitation prior to comprehensive neurologic assessment and advanced imaging.
Soru 680Soru →

A 5454-year-old man with a history of chronic alcohol use disorder and severe malnutrition is brought to the emergency department after a witnessed generalized tonic-clonic seizure. On arrival, he is postictal. Initial laboratory studies reveal a serum sodium concentration of 104 mEq/L104 \text{ mEq/L}. He is promptly treated with two 100 mL100 \text{ mL} intravenous boluses of 3%3\% sodium chloride, which aborts any further clinical seizure activity. He is transferred to the intensive care unit, and a continuous infusion of 0.9%0.9\% sodium chloride is initiated.

Six hours later, the patient is awake and oriented to person and place. Repeat laboratory studies show a serum sodium concentration of 115 mEq/L115 \text{ mEq/L}. Over the past two hours, the patient's urine output has increased to 600 mL/hour600 \text{ mL/hour}. A spot urine osmolality is 85 mOsm/kg85 \text{ mOsm/kg}.

Which of the following is the most appropriate next step in the management of this patient's fluid and electrolyte status?

Cevabı ve açıklamayı göster

Cevap: Discontinue the current intravenous fluids and administer 5%5\% dextrose in water with desmopressin

Cevap

The most appropriate next step is to discontinue the current fluids and administer 5% dextrose in water concurrently with desmopressin.
This patient presented with severe, chronic hyponatremia (104 mEq/L104 \text{ mEq/L}) and possesses multiple risk factors for osmotic demyelination syndrome (ODS), specifically chronic alcohol use disorder and severe malnutrition. For patients at high risk of ODS, the absolute maximum safe rate of serum sodium correction is 8 mEq/L8 \text{ mEq/L} in any 2424-hour period (many guidelines suggest a stricter 6 mEq/L6 \text{ mEq/L} limit). This patient's sodium has rapidly climbed by 11 mEq/L11 \text{ mEq/L} in only 66 hours, drastically breaching the safety limit. Furthermore, the clinical data of polyuria (600 mL/hour600 \text{ mL/hour}) with a profoundly dilute urine (85 mOsm/kg85 \text{ mOsm/kg}) indicates the patient is undergoing an active aquaresis. Without intervention, his sodium will continue to rise rapidly. Passive management (just stopping the saline) is insufficient. The standard of care for severe hyponatremia overcorrection requires "therapeutic re-lowering" of the serum sodium. This is achieved by administering a free water source (like intravenous 5%5\% dextrose in water) to drive the sodium concentration down, combined with desmopressin (an ADH analog) to clamp the kidneys and halt the ongoing free water diuresis.

Adım Adım Çözüm

1
Assess the patient's baseline risk profile for osmotic demyelination syndrome (ODS).
The patient has severe initial hyponatremia (104 mEq/L104 \text{ mEq/L}), chronic alcohol use disorder, and malnutrition, placing him at extremely high risk for ODS.
High-risk patients have a strict sodium correction limit of 66 to 8 mEq/L8 \text{ mEq/L} per 2424-hour period to prevent permanent neurological damage.
2
Evaluate the current trajectory of the serum sodium correction.
The sodium has increased from 104 mEq/L104 \text{ mEq/L} to 115 mEq/L115 \text{ mEq/L}, representing an 11 mEq/L11 \text{ mEq/L} rise in just 66 hours, massively exceeding the 8 mEq/L8 \text{ mEq/L} maximum safety threshold for a full 2424-hour period.
Recognizing overcorrection is critical to triggering the rescue protocol.
3
Interpret the current urine studies to predict the next sodium shift.
The very high urine output (600 mL/hour600 \text{ mL/hour}) and severely dilute urine (85 mOsm/kg85 \text{ mOsm/kg}) indicate active aquaresis (a massive free water diuresis).
The initial hyponatremia stimulus for ADH has resolved, leading to suppression of ADH. The kidneys are rapidly dumping free water, meaning the serum sodium will continue to skyrocket unless actively stopped.
4
Select the appropriate pharmacologic and fluid intervention.
Discontinue normal saline. Start 5%5\% dextrose in water (D5W) to replace the free water being lost, and administer desmopressin (DDAVP) to stop the renal aquaresis.
This combination clamps the kidneys, stopping the free water loss, while therapeutically re-lowering the serum sodium back into the safe 2424-hour target range.

Anahtar Kavram

Overcorrection of severe hyponatremia (a rise >8 mEq/L> 8 \text{ mEq/L} in 2424 hours) in high-risk patients requires immediate active re-lowering with intravenous free water (5%5\% dextrose in water) and desmopressin to prevent osmotic demyelination syndrome.
Tahmini Süre:2m 0s
ÖncekiSayfa 34 / 104Sonraki